| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |